SCHEMBL19356293

SCHEMBL19356293

CCOc1cc(-c2nnc(C)o2)ccc1C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 5/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HPGD P15428 9/20 0.51
KDM4E B2RXH2 9/20 0.51
HSD17B10 Q99714 8/20 0.51
ALDH1A1 P00352 8/20 0.51
RAB9A P51151 6/20 0.51
MAPK1 P28482 3/20 0.51
LMNA P02545 2/20 0.51
NPC1 O15118 5/20 0.50
NPSR1 Q6W5P4 1/20 0.48
TLR8 Q9NR97 1/20 0.46
TLR7 Q9NYK1 1/20 0.46
TSHR P16473 2/20 0.45
PRMT5 O14744 1/20 0.45
MAPT P10636 3/20 0.44
NOD2 Q9HC29 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.41
TP53 P04637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21958358 0.86 TLR8 (0.56) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL23349276 0.84 S1PR1 (0.56) S1PR1MEN1KMT2AHPGDKDM4E
SCHEMBL20784239 0.81 ALDH1A1 (0.48) S1PR1MEN1KMT2AHPGDKDM4E
SCHEMBL8280967 0.79 KMT2A (0.53) S1PR1MEN1KMT2AHPGDKDM4E
SCHEMBL22838723 0.78 TLR8 (0.49) S1PR1MEN1KMT2AHPGDKDM4E
SCHEMBL17559462 0.78 PRMT5 (0.55) S1PR1MEN1KMT2AHPGDKDM4E
SCHEMBL22214066 0.77 SNCA (0.50) HPGDHSD17B10ALDH1A1RAB9ALMNA
SCHEMBL11994392 0.77 HDAC6 (0.44) HPGDHSD17B10ALDH1A1RAB9ALMNA
SCHEMBL17559379 0.76 PRMT5 (0.53) S1PR1MEN1KMT2AHPGDKDM4E
SCHEMBL8282012 0.74 KDM4E (0.71) MEN1KMT2AHPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426648-B1 TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS CTXT PTY LTD (AU) 2021-05-12 EP disclosed
US-10421743-B2 Tetrahydroisoquinolines as PRMT5 inhibitors CTXT PTY LTD (AU) 2019-09-24 US disclosed
US-20190071425-A1 TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS CTXT PTY LTD (AU) 2019-03-07 US disclosed
WO-2017153513-A1 TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS CTXT PTY LIMITED (AU) 2017-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190071425-A1 TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 S1PR1 2730/4885MEN1 162/4885KMT2A 46/4885
US-10421743-B2 Tetrahydroisoquinolines as PRMT5 inhibitors PRMT5, PRMT1, PRMT3 S1PR1 2730/4885MEN1 162/4885KMT2A 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.